Development of functionalized nanoparticles for vaccine delivery to dendritic cells: a mechanistic approach.
about
Translational nanoparticle engineering for cancer vaccines.Inorganic nanoparticles as potential regulators of immune response in dendritic cells.C-Type lectin receptor(s)-targeted nanoliposomes: an intelligent approach for effective cancer immunotherapy.Systematic Overview of Solid Particles and Their Host Responses.Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer ImmunotherapyOptimization of protein loaded PLGA nanoparticle manufacturing parameters following a quality-by-design approachα-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma
P2860
Q46720677-B7A7DFC1-6DF6-4593-99B3-41476869A3F8Q50932486-864070E9-CD5A-4423-B87F-E903828F6BE1Q54139494-74FEA360-09A4-4B19-8D7B-C5AAC8239977Q55216329-DA1246FC-6189-49D5-A4E8-7101B6272D8AQ57492118-C37EF0CD-4B18-4495-B3CC-ADA883DF1A1FQ57656129-D9F3702E-7637-463A-B69C-6DC244B02FDBQ59134498-14B3DA41-A1DE-4F1F-ABE0-DD4408BC94E0
P2860
Development of functionalized nanoparticles for vaccine delivery to dendritic cells: a mechanistic approach.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Development of functionalized ...... cells: a mechanistic approach.
@en
type
label
Development of functionalized ...... cells: a mechanistic approach.
@en
prefLabel
Development of functionalized ...... cells: a mechanistic approach.
@en
P2093
P2860
P50
P356
P1433
P1476
Development of functionalized ...... cells: a mechanistic approach.
@en
P2093
Ana Salgado
Carlos A Afonso
Joana M Silva
Vanessa G Oliveira
Véronique Préat
P2860
P304
P356
10.2217/NNM.14.135
P50
P577
2014-12-01T00:00:00Z